Peter Kamper
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
- Neutropenia and Cancer Infections
Papers in
-
- Lymphoma Diagnosis and Treatment 44
- Oncology 7
- Viral-associated cancers and disorders 3
- Neutropenia and Cancer Infections 2
- Co-authors
- Francesco d’Amore (28 shared papers)Stephen Jacques Hamilton-Dutoit (16 shared papers)Knud Bendix (8 shared papers)Bent Honoré (10 shared papers)Jens Randel Nyengaard (2 shared papers)Maja Ludvigsen (11 shared papers)Michael Roost Clausen (4 shared papers)Ingrid Cecilia Glimelius (11 shared papers)
In The Last Decade
Peter Kamper
51 papers receiving 806 citations
Peter Kamper's Hit Papers
Peers
Comparison fields: 5 of 50
- Pathology and Forensic Medicine 544
- Oncology 121
- Immunology 100
- Health Informatics 5
- Hematology 27
Countries citing papers authored by Peter Kamper
This map shows the geographic impact of Peter Kamper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kamper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kamper more than expected).
Fields of papers citing papers by Peter Kamper
This network shows the impact of papers produced by Peter Kamper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kamper. The network helps show where Peter Kamper may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Kamper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 171 | |
| 2 | 2011 | 72 | |
| 3 | Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial Hit paper breakdown → | 2024 | 68 |
| 4 | 2016 | 56 | |
| 5 | 2017 | 44 | |
| 6 | 2017 | 42 | |
| 7 | 2015 | 39 | |
| 8 | 2018 | 27 | |
| 9 | 2013 | 24 | |
| 10 | 2015 | 22 | |
| 11 | 2020 | 22 | |
| 12 | 2023 | 17 | |
| 13 | 2017 | 16 | |
| 14 | 2005 | 15 | |
| 15 | 2021 | 15 | |
| 16 | 2020 | 12 | |
| 17 | 2021 | 11 | |
| 18 | 2022 | 11 | |
| 19 | 2015 | 10 | |
| 20 | 2024 | 10 |
About Peter Kamper
Peter Kamper is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Epidemiology and Public Health, Environmental and Occupational Health, having authored 52 papers that have together received 821 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (44 papers), Viral-associated cancers and disorders (3 papers), Galectins and Cancer Biology (2 papers), Multiple and Secondary Primary Cancers (2 papers), Reproductive Biology and Fertility (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (544 citations), Oncology (121 citations), Immunology (100 citations), Health Informatics (5 citations) and Hematology (27 citations). Peter Kamper has collaborated with scholars based in Denmark, Sweden and Norway. Frequent co-authors include Francesco d’Amore, Stephen Jacques Hamilton-Dutoit, Knud Bendix, Bent Honoré, Jens Randel Nyengaard, Maja Ludvigsen, Michael Roost Clausen, Ingrid Cecilia Glimelius, Michael Boe Møller and Karin Ekstrom Ekstroem Smedby. Their work appears in journals such as British Journal of Haematology, Blood, European Journal Of Haematology, Haematologica and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.